EUVIMEDEUVIMED entdecken
Crossref

A zinc–glycyrrhizic acid hydrogel alleviates atopic dermatitis by targeting the TLR4/NLRP12-driven PANoptosis axis

Dan Wang, Yaling Wei, Shenming Xu, Daijing Long, Pei Li, Yankun Li, Jun Zhu, Wenhu Zhou

Journal of Controlled Release · 2026

DOI: 10.1016/j.jconrel.2026.115142 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Controlled Release, 2026. Verfasst von Dan Wang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, The Third Xiangya Hospital, Central South University, Changsha, Hunan 410000, China. Hauptthemen laut MEDLINE: Dermatitis, Atopic, Hydrogels, Zinc, Glycyrrhizic Acid. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 79 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Hunan Provincial Natural Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Atopic dermatitis (AD) is a chronic inflammatory skin disease characterized by epidermal barrier dysfunction and immune dysregulation. Increasing evidence suggests that dysregulated programmed cell death in keratinocytes and immune cells contributes critically to AD pathogenesis; however, the integrated mechanisms underlying these processes remain poorly understood. Here, we report the construction of a zinc-glycyrrhizic acid supramolecular hydrogel (ZnGA) via metal-ligand coordination and investigate its therapeutic potential and mechanism in AD. ZnGA exhibits excellent injectability, self-healing ability, and biocompatibility, enabling controlled release of Zn2+ and exerting anti-inflammatory activity. In a murine AD model and corresponding in vitro systems, ZnGA significantly alleviates skin inflammation, epidermal hyperplasia, and immune infiltration. Transcriptomic analysis reveals that ZnGA markedly suppresses inflammation-associated programmed cell death pathways, particularly those converging on PANoptosis. Mechanistic studies demonstrate that AD is accompanied by coordinated activation of apoptosis, pyroptosis, and necroptosis in keratinocytes and macrophages. ZnGA simultaneously inhibits these death modalities, thereby exerting a broad-spectrum anti-PANoptotic effect, while exerting an immune protective effect. Further investigation identifies the TLR4/NLRP12 signaling axis as a critical upstream regulator of PANoptosis in AD. ZnGA negatively regulates TLR4 and NLRP12 expression, effectively blocking downstream activation of PANoptosome-associated apoptotic, pyroptotic, and necroptotic pathways. Collectively, this study identifies PANoptosis as a key pathogenic mechanism in AD and presents ZnGA as a novel supramolecular therapeutic that alleviates AD by targeting the TLR4-NLRP12-PANoptosis axis. These findings provide new mechanistic insight and a promising materials-based strategy for the treatment of inflammatory skin diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Dermatitis, AtopicHydrogelsZincGlycyrrhizic AcidAnti-Inflammatory AgentsAnimalsToll-Like Receptor 4MiceKeratinocytesIntracellular Signaling Peptides and ProteinsHumansMice, Inbred C57BLApoptosis

Stichwörter der Autor:innen

Inflammatory skin diseaseMacrophage polarizationMetal–ligand coordinationProgrammed cell deathTherapeutic hydrogel

Substanzen

Toll-Like Receptor 4HydrogelsZincGlycyrrhizic AcidAnti-Inflammatory AgentsTlr4 protein, mouseIntracellular Signaling Peptides and Proteins

Autor:innen und Institutionen

  • Department of Dermatology, The Third Xiangya Hospital, Central South University, Changsha, Hunan 410000, China.
  • Xiangya School of Pharmaceutical Sciences, Central South University, Changsha, Hunan 410013, China.
  • Xiangya School of Pharmaceutical Sciences, Central South University, Changsha, Hunan 410013, China; Hunan BeautySci Biotech Co., Ltd, Hunan 410122, PR China.
  • Guangzhou Liyan Cosmetics Technology Co., Ltd, Guangzhou, Guangdong 510470, China.
  • Xiangya School of Pharmaceutical Sciences, Central South University, Changsha, Hunan 410013, China; Hunan BeautySci Biotech Co., Ltd, Hunan 410122, PR China; Hunan Key Laboratory of The Research and Development of Novel…

Förderung

  • National Natural Science Foundation of China
  • Hunan Provincial Natural Science Foundation

Zitieren

APA

Wang, D., Wei, Y., Xu, S., Long, D., Li, P., Li, Y., Zhu, J., & Zhou, W. (2026). A zinc–glycyrrhizic acid hydrogel alleviates atopic dermatitis by targeting the TLR4/NLRP12-driven PANoptosis axis. Journal of Controlled Release. https://doi.org/10.1016/j.jconrel.2026.115142

Vancouver

Wang D, Wei Y, Xu S, Long D, Li P, Li Y, et al. A zinc–glycyrrhizic acid hydrogel alleviates atopic dermatitis by targeting the TLR4/NLRP12-driven PANoptosis axis. Journal of Controlled Release. 2026. doi:10.1016/j.jconrel.2026.115142

BibTeX
@article{Wang2026,
  author = {Wang, Dan and Wei, Yaling and Xu, Shenming and Long, Daijing and Li, Pei and Li, Yankun and Zhu, Jun and Zhou, Wenhu},
  title = {A zinc–glycyrrhizic acid hydrogel alleviates atopic dermatitis by targeting the TLR4/NLRP12-driven PANoptosis axis},
  journal = {Journal of Controlled Release},
  year = {2026},
  doi = {10.1016/j.jconrel.2026.115142}
}
Kostenlos starten →